Russell Investments Group Ltd. acquired a new position in shares of Zevia PBC (NYSE:ZVIA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 142,274 shares of the company's stock, valued at approximately $596,000. Russell Investments Group Ltd. owned approximately 0.19% of Zevia PBC at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its position in shares of Zevia PBC by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 539,652 shares of the company's stock worth $2,262,000 after buying an additional 3,177 shares in the last quarter. Emerald Advisers LLC purchased a new stake in shares of Zevia PBC in the fourth quarter valued at about $228,000. SBI Securities Co. Ltd. acquired a new stake in shares of Zevia PBC in the fourth quarter valued at approximately $57,000. Abacus Planning Group Inc. acquired a new stake in shares of Zevia PBC in the fourth quarter valued at approximately $57,000. Finally, Calamos Advisors LLC purchased a new position in shares of Zevia PBC during the 4th quarter worth approximately $471,000. 53.21% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on ZVIA. Telsey Advisory Group decreased their price target on shares of Zevia PBC from $4.00 to $3.00 and set a "market perform" rating on the stock in a research note on Thursday, February 27th. The Goldman Sachs Group upped their price objective on shares of Zevia PBC from $1.15 to $3.75 and gave the company a "neutral" rating in a research note on Tuesday, January 14th.
Read Our Latest Stock Report on ZVIA
Zevia PBC Stock Up 3.7 %
Shares of NYSE ZVIA opened at $2.39 on Wednesday. The stock has a market capitalization of $175.32 million, a PE ratio of -6.28 and a beta of 0.77. The firm has a fifty day moving average of $2.41 and a 200-day moving average of $2.68. Zevia PBC has a 52-week low of $0.62 and a 52-week high of $4.99.
Zevia PBC Company Profile
(
Free Report)
Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.
Featured Articles
Want to see what other hedge funds are holding ZVIA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zevia PBC (NYSE:ZVIA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zevia PBC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.
While Zevia PBC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.